Navigation Links
Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine?
Date:9/1/2009

ealth to provide to the disaster areas a large amount of disinfectant, of which more than 400 tons were transported by air due to urgent need.

"We are carrying out R&D on new types of disinfectant to combat the influenza virus," Chairman Xuelian Bian emphasized, "Over the past few years, Likang has focused on the medical disinfection market in China, rejecting offers of cooperation from institutional investors who have wanted to invest in the civilian public health market many times. Nevertheless, the situation of the outbreak of infectious diseases throughout the world is becoming more urgent. China's 1.3 billion people make up a more than 30 billion market shares in the huge market of infection control. To Likang company, which holds a large number of civilian disinfection product technology patents, the decision to penetrate the civil disinfection market and other related markets will not only provide the most professional products and services to the whole community, but also lead to rapid growth and expansion for the company."

About Linkwell Corporation

Linkwell Corporation, through its 90% ownership of its subsidiary, Shanghai Likang Disinfectant Hi-tech Co., Ltd, develops, manufactures and distributes disinfectant healthcare products in China. Founded in 1998, Shanghai Likang Disinfectant Hi-tech Co., Ltd, has developed into China's top-ranked medical disinfection high-tech enterprise with several years' rapid growth. Formerly a Second Military Medical University-owned technology company, Likang always attaches great importance to the R&D and sales of new sterilization products. The company has obtained most disinfection product licenses approved by the Ministry of Health, and is equipped with the all the liquid, gel, powder and tablet production lines. The company is in possession of 12 patents and has 25 others in process, as well as a great deal of know-how. The company can put for
'/>"/>

SOURCE Linkwell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pelosi Statement on House Passage of Labor, HHS, Appropriations Bill, Which Lifts Ban on Needle Exchange
2. Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best, a Major Advance in Fixing Our Broken Health-Care System
3. California Shock Trauma Air Rescue (CALSTAR) Leads the Way in Pioneering Helicopter Modification Which is Expected to Greatly Enhance Safety and Save Lives
4. Skin and Skin Structure Infections Are the Second Most Common Diagnoses for Which an Antibiotic Is Used in the Hospital Setting
5. Health Reform Press Conference on June 18: Which Bills Will Preserve Privacy Rights and Patient Choice?
6. American Association for Homecare Applauds Senate STOP Act, Which Aims to Prevent Medicare Fraud and Abuse
7. Stress Management Author Asks "Which Will Cost You More: The Recession or Stress?"
8. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
9. When physical and mental health problems co-occur and money gets tight, which prescriptions go unfilled?
10. US experiencing primary care shortage likes of which we have not seen
11. Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... ... When it comes to undergoing a hair transplant, most patients have donor hair moved from ... to the hair on top of the scalp, as well as filling in areas missing ... hair on other areas of their head. , What about patients who have a limited, ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a ... ” tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits ... to help India Network members make an informed decision regarding the care they ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... The Lisle ... Firm Partner William Scott has been nominated by his peers to earn a “Leading ... than five percent of attorneys in the state of Illinois. The nomination process is ...
(Date:8/31/2015)... ... August 31, 2015 , ... The 2015 ... to patients and family members, medical professionals, and researchers, covering a variety of ... conference is a collaborative effort between the Mesothelioma Applied Research Foundation ...
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, a nonprofit Ohio-based health ... this capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications ... that have contributed to the company’s rapid growth. As the CareSource business model ...
Breaking Medicine News(10 mins):Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... , ... Dr. Hamid Nassery, offers dental massage to relax patients, treat TMJ disorders and improve dental ... Miami, FLA. (PRWEB) ... dentist Dr. Hamid Nassery and his team at Miami Beach Dental Institute now offer dental ...
... For ... all the limits and test the Social Media world on a whole other level , ... Florida (PRWEB) March 25, 2010 -- Take a ... O2 Media, Inc ., and previously V.P. of HR at IBM and CEO of Bank of ...
... -- A sun protection intervention program that encouraged fourth-graders ... measure significantly increased hat use at school, a study by ... found. The program, however, had no effect on self-reported ... The study is published online this month in the ...
... three-quarters of whites, Hispanics, CDC says , THURSDAY, March ... of breast-feeding aren,t reaching black American women as well ... from the U.S. Centers for Disease Control and Prevention ... than 80 percent of Hispanic mothers attempt to breast-feed, ...
... About 40 percent of children and up to 70 percent ... have a relapse. In recent years, doctors have come to ... replicating cancer cells that generate the immature blood cells characteristic ... researchers at Children,s Hospital Boston have found a possible way ...
... Research with mice might one day yield new therapies, ... When used with chemotherapy, an experimental synthetic drug called ... a new study found. , JP1201 mimics that action ... death. , In this study, researchers gave JP1201 and ...
Cached Medicine News:Health News:Top Miami Dentist, Dr. Hamid Nassery, Offers Dental Massage Services For Patients 2Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 2Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 3Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 4Health News:Sun protection program increases hat use among 4th-graders 2Health News:Sun protection program increases hat use among 4th-graders 3Health News:Black Women Least Likely to Breast-Feed in U.S. 2Health News:Black Women Least Likely to Breast-Feed in U.S. 3Health News:Targeting cell pathway may prevent relapse of leukemia 2Health News:Targeting cell pathway may prevent relapse of leukemia 3Health News:Chemo Plus Synthetic Drug Shrunk Pancreatic Tumors 2
(Date:8/31/2015)... Aug. 31, 2015  Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today it has completed enrollment of the ... Committee (DRC) earlier this year, into the company,s ... first-in-class innate defense regulator (IDR) and is being ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... , HELSINKI, Dec. 14 Cancer ... with the introduction of RapidArc® radiotherapy technology from Varian Medical ... radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic ... radiotherapy to treat patients with multiple brain metastases and cancers ...
... , WALTHAM, Mass., Dec. ... authority on medical technology market intelligence, increased use of safety ... be a key driver of the enteral feeding device markets ... and European Markets for Enteral Feeding Devices 2010 report ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: